PITTSBURGH, March 16 /PRNewswire/ -- The following was issued today by
Bayer Corporation:
Bayer Corporation President and CEO Helge H. Wehmeier and Dr. Wolfgang
Plischke, President of Bayer Pharmaceutical N.A., will release Bayer's latest
performance results, discuss industry developments and present current growth
strategies for Bayer's health care and life sciences and chemicals units.
Highlights Include:
-- 2000 Performance
-- Recent Acquisitions, Cost Savings Initiatives & E-commerce Successes
-- Strategic Initiatives for 2001
Headquartered in Pittsburgh, Bayer Corporation is the largest subsidiary
of the worldwide Bayer Group (DAX: BAYG.DE), a $29 billion international life
sciences, polymers and specialty chemicals group based in Leverkusen, Germany.
Bayer Corp. has over 23,000 employees in more than 50 locations throughout the
United States, including key operations in New Jersey, New York, Connecticut,
California, Missouri, Texas, South Carolina and West Virginia. Bayer Corp.'s
nine operating divisions include Pharmaceutical; Consumer Care; Diagnostics;
Agriculture; Polyurethanes; Industrial Chemicals; Fibers, Additives and
Rubber; Plastics; and Coatings and Colorants. The Bayer Group plans to list
its stock on the New York Stock Exchange later this year. For more
information, please visit http://www.BayerUS.com.
For further details or to participate, please e-mail
bayer@taylor-rafferty.com; or contact Christina Eichhorn at 212-889-4350.
Note: Upon registration, all dial-in numbers will be made available. More
information can be found on the Bayer web site at http://www.BayerUS.com.
SOURCE Bayer Corporation
 back to top
Related links:
http://www.bayerus.com
Company News On-Call:
http://www.prnewswire.com/comp/092575.html or fax,
800-758-5804, ext. 092575
CONTACT:
Christina Eichhorn, 212-889-4350 or
bayer@taylor-rafferty.com, for Bayer
|
